OAS1 and COVID-19: Interestingly, OAS1 (2’-5’-Oligoadenylate Synthetase 1) shows higher expression in patients with mild symptoms (Figure 5B), which agrees with the recent findings that higher plasma OAS1 concentrations are associated with reduced COVID-19 severity (55).